Micol Ravà

8PUBLICATIONS
55CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Innate immunityAgricultural molecular engineering of nucleic acids and proteinsNeural engineeringCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Jun 30, 2025
CD4+ T cells license Kupffer cells to reverse CD8+ T cell dysfunction induced by hepatocellular priming.

Valentina Venzin, Cristian G Beccaria, Chiara Perucchini

|Mar 15, 2024
Antibody-independent protection against heterologous SARS-CoV-2 challenge conferred by prior infection or vaccination.

Valeria Fumagalli, Micol Ravà, Davide Marotta

|Oct 28, 2023
Immunogenicity and Pre-Clinical Efficacy of an OMV-Based SARS-CoV-2 Vaccine.

Alberto Grandi, Michele Tomasi, Irfan Ullah

|Jun 09, 2023
Immunogenicity and pre-clinical efficacy of an OMV-based SARS-CoV-2 vaccine.

Alberto Grandi, Michele Tomasi, Irfan Ullah

|Feb 25, 2022
Group 1 ILCs regulate T cell-mediated liver immunopathology by controlling local IL-2 availability.

Valeria Fumagalli, Valentina Venzin, Pietro Di Lucia

|Nov 23, 2021
Administration of aerosolized SARS-CoV-2 to K18-hACE2 mice uncouples respiratory infection from fatal neuroinvasion.

Valeria Fumagalli, Micol Ravà, Davide Marotta

Pageof 2

Frequent Collaborators

5 joint publications

Matteo Iannacone

5 joint publications

Valeria Fumagalli

4 joint publications

Mirela Kuka

4 joint publications

Luca G Guidotti